Site selection in global clinical trials in patients hospitalized for heart failure: Perceived problems and potential solutions

Heart Failure Reviews

Volumn 19, Issue 2, 2014, Pages 135-152

  Gheorghiade, Mihai ^a   Vaduganathan, Muthiah ^b   Greene, Stephen J ^a   Mentz, Robert J ^c   Adams Jr , Kirkwood F ^d   Anker, Stefan D ^e   Arnold, Malcolm ^f   Baschiera, Fabio ^g   Cleland, John G F ^h   Cotter, Gadi ⁱ   Fonarow, Gregg C ^j   Giordano, Christopher ^k   Metra, Marco ^l   Misselwitz, Frank ^m   Mühlhofer, Eva ⁿ   Nodari, Savina ^l   Frank Peacock, W ^o   Pieske, Burkert M ^p   Sabbah, Hani N ^q   Sato, Naoki ^r   Shah, Monica R ^s   Stockbridge, Norman L ^t   Teerlink, John R ^u   Van Veldhuisen, Dirk J ^v   Zalewski, Andrew ^g   Zannad, Faiez ^w   Butler, Javed ^x   more..

^a NORTHWESTERN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e IRCCS SAN RAFFAELE PISANA   (Italy)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g NOVARTIS PHARMA AG   (Switzerland)

^h CASTLE HILL HOSPITAL   (United Kingdom)

ⁱ Momentum Research Inc   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k IQVIA   (United States)

^l UNIVERSITY OF BRESCIA   (Italy)

^m BAYER PHARMA AG   (Germany)

ⁿ BAYER AG   (Germany)

^o BAYLOR COLLEGE OF MEDICINE   (United States)

^p MEDICAL UNIVERSITY OF GRAZ   (Austria)

^q HENRY FORD HOSPITAL   (United States)

^r NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^s NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^t CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^w UNIVERSITÉ DE LORRAINE   (France)

^x EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Clinical trials; FDA; Heart failure; Site selection

Indexed keywords

ALISKIREN; BRAIN NATRIURETIC PEPTIDE; EPLERENONE; NESIRITIDE; TOLVAPTAN; VASOPRESSIN;

ACUTE HEART FAILURE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); COMORBIDITY; CONFLICT OF INTEREST; DISEASE REGISTRY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DISPARITY; HEALTH CARE POLICY; HEART FAILURE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; PATIENT AUTONOMY; PATIENT PARTICIPATION; PATIENT SAFETY; PATIENT SELECTION; PEER REVIEW; PHYSICIAN INCOME; PROGNOSIS; REIMBURSEMENT; SELECTION BIAS; STUDY DESIGN;

CLINICAL TRIALS AS TOPIC; HEART FAILURE; HOSPITALIZATION; HUMANS; INPATIENTS; PATIENT SELECTION; RESEARCH DESIGN; THERAPIES, INVESTIGATIONAL; UNITED STATES;

EID: 84896726059     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-012-9361-8     Document Type: Article

References (32)

1. Konstam MA, Gheorghiade M, Burnett JC, Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orland C, Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan I (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297(12):1319-1331. doi: 10.1001/jama.297.12.1319
2. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalan R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Mendez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM (2011) Effect of nesiritide in patients with acute decompensated heart failure. New England J Med 365(1):32-43. doi: 10.1056/NEJMoa1100171
3. Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC (2010) Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. New England J Med 363(15):1419-1428. doi: 10.1056/NEJMoa0912613
4. Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S, Andre S, Mark Courtney D, Hasa J, Spinar J, Masip J, Frank Peacock W, Sliwa K, Gayat E, Filippatos G, Cleland JG, Gheorghiade M (2010) The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J 31(7):832-841. doi: 10.1093/eurheartj/ehp458
5. Allen LA, Hernandez AF, O'Connor CM, Felker GM (2009) End points for clinical trials in acute heart failure syndromes. J Am Coll Cardiol 53(24):2248-2258. doi: 10.1016/j.jacc.2008.12.079
6. Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50(8):768-777. doi: 10.1016/j.jacc.2007.04.064
7. Gheorghiade M, Pang PS, O'Connor CM, Prasad K, McMurray J, Teerlink JR, Fiuzat M, Sabbah H, Komajda M (2011) Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase. Am Heart J 161(2):224-232. doi: 10.1016/j.ahj.2010.10.023
8. Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M (2010) Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail 3(2):314-325. doi: 10.1161/CIRCHEARTFAILURE.109.893222
9. Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Pina IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N (2009) Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J 157(6):957-970. doi: 10.1016/j.ahj.2009.04.010
10. Gheorghiade M, Zannad F, Sopko G, Klein L, Pina IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L (2005) Acute heart failure syndromes: current state and framework for future research. Circulation 112(25):3958-3968. doi: 10.1161/CIRCULATIONAHA.105.590091
11. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J (2010) Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121(7):e46-e215. doi: 10.1161/CIRCULATIONAHA.109.192667
12. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC (2006) Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA, J Am Med Assoc 296(18):2217-2226. doi: 10.1001/jama.296.18.2217
13. Gheorghiade M, Pang PS (2009) Acute heart failure syndromes. J Am Coll Cardiol 53(7):557-573. doi: 10.1016/j.jacc.2008.10.041
14. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP, Committee ASA, Investigators (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149(2):209-216. doi: 10.1016/j.ahj.2004.08.005
15. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J, Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of C (2003) The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24(5):442-463
16. Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Pina IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N, Acute Heart Failure Syndromes International Working G (2009) Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J 157(6):957-970. doi: 10.1016/j.ahj.2009.04.010
17. Gheorghiade M, Albaghdadi M, Zannad F, Fonarow GC, Bohm M, Gimpelewicz C, Botha J, Moores S, Lewis EF, Rattunde H, Maggioni A, Investigators A, study c (2011) Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT). Eur J Heart Fail 13(1):100-106. doi: 10.1093/eurjhf/hfq209
18. Gheorghiade M, Braunwald E (2011) Hospitalizations for heart failure in the United States-a sign of hope. JAMA 306(15):1705-1706. doi: 10.1001/jama.2011.1510
19. Gheorghiade M, Pang PS, O'Connor CM, Prasad K, McMurray J, Teerlink JR, Fiuzat M, Sabbah H, Komajda M (2011) Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase. Am Heart J 161(2):224-232. doi: 10.1016/j.ahj.2010.10.023
20. Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM (2012) Rivaroxaban in patients with a recent acute coronary syndrome. New England J Med 366(1):9-19. doi: 10.1056/NEJMoa1112277
21. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, Group E-HS (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364(1):11-21. doi: 10.1056/NEJMoa1009492
22. Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, Califf RM, Schulman KA (2009) Ethical and scientific implications of the globalization of clinical research. New England J Med 360(8):816-823. doi: 10.1056/NEJMsb0803929
23. Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC Jr, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M (2008) Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol 52(20):1640-1648. doi: 10.1016/j.jacc.2008.07.056
24. Finn R (2000) Oncologist's role critical to clinical trial enrollment. J Natl Cancer Inst 92(20):1632-1634
25. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB (2012) Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046
26. Fonarow GC (2011) Improving quality of care and outcomes for heart failure: role of registries. Circ J 75(8):1783-1790
27. Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB (2007) Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med 167(14):1493-1502. doi: 10.1001/archinte.167.14.1493
28. Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC (1995) A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. New England J Med 333(25):1670-1676. doi: 10.1056/NEJM199512213332503
29. Sato N, Kajimoto K, Asai K, Mizuno M, Minami Y, Nagashima M, Murai K, Muanakata R, Yumino D, Meguro T, Kawana M, Nejima J, Satoh T, Mizuno K, Tanaka K, Kasanuki H, Takano T (2010) Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J 159(6):949-955 e941. doi: 10.1016/j.ahj.2010.03.019
30. Minami Y, Kajimoto K, Sato N, Yumino D, Mizuno M, Aokage T, Murai K, Munakata R, Asai K, Sakata Y, Keida T, Hagiwara N, Mizuno K, Kasanuki H, Takano T (2011) Admission time, variability in clinical characteristics, and in-hospital outcomes in acute heart failure syndromes: findings from the ATTEND registry. Int J Cardiol 153(1):102-105. doi: 10.1016/j.ijcard.2011.09.020
31. Takahashi M, Kohsaka S, Miyata H, Yoshikawa T, Takagi A, Harada K, Miyamoto T, Sakai T, Nagao K, Sato N, Takayama M (2011) Association between prehospital time interval and short-term outcome in acute heart failure patients. J Cardiac Fail 17(9):742-747. doi: 10.1016/j.cardfail.2011.05.005
32. Massie BM (2011) Globalization of clinical trials how should we interpret differences in outcomes? J Am Coll Cardiol 58(9):923-924. doi: 10.1016/j.jacc.2011.04.027